← Back to Search

Supraglottic Airway Device

Endoscopic Retrograde Cholangiopancreatography for Cholangiocarcinoma

N/A
Waitlist Available
Led By Katherine Hagan
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to completion of endoscopic retrograde cholangiopancreatography
Awards & highlights

Study Summary

This trial compares the LMA Gastro to oxygenation with standard nasal cannula for endoscopic retrograde cholangiopancreatography (ERCP).

Eligible Conditions
  • Cholangiocarcinoma
  • Gallbladder Cancer
  • Pancreatic Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to completion of endoscopic retrograde cholangiopancreatography
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to completion of endoscopic retrograde cholangiopancreatography for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of desaturations (oxygen saturation [SpO2] < 90%)
Secondary outcome measures
Incidence of additional airway maneuvers
Incidence of adverse events
Incidence of withdrawal of duodenoscope from airway to facilitate airway support

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (ERCP with LMA Gastro)Experimental Treatment1 Intervention
Patients undergo ERCP with LMA Gastro.
Group II: Arm II (ERCP with standard nasal cannula)Active Control1 Intervention
Patients undergo ERCP with standard nasal cannula.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Endoscopic Retrograde Cholangiopancreatography
2016
N/A
~530

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,987 Previous Clinical Trials
1,798,169 Total Patients Enrolled
14 Trials studying Cholangiocarcinoma
3,999 Patients Enrolled for Cholangiocarcinoma
National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,953,248 Total Patients Enrolled
102 Trials studying Cholangiocarcinoma
9,770 Patients Enrolled for Cholangiocarcinoma
Katherine HaganPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
33 Total Patients Enrolled
~16 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top